Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;96(6):e6053.
doi: 10.1097/MD.0000000000006053.

Significant elevation of biomarkers of myocardial necrosis after coronary artery bypass grafting without myocardial infarction established assessed by cardiac magnetic resonance

Leandro Menezes Alves da Costa  1 , Whady Hueb, Cesar Higa Nomura, Alexandre Ciappina Hueb, Alexandre Volney Villa, Fernando Teiichi Costa Oikawa, Rodrigo Morel Vieira de Melo, Paulo Cury Rezende, Carlos Alexandre Wainrober Segre, Cibele Larrosa Garzillo, Eduardo Gomes Lima, Jose Antonio Franchini Ramires, Roberto Kalil Filho
Affiliations

Significant elevation of biomarkers of myocardial necrosis after coronary artery bypass grafting without myocardial infarction established assessed by cardiac magnetic resonance

Leandro Menezes Alves da Costa et al. Medicine (Baltimore). 2017 Feb.

Abstract

The release of myocardial necrosis biomarkers after off-pump coronary artery bypass grafting (OPCAB) frequently occurs. However, the correlation between biomarker release and the diagnosis of procedure-related myocardial infarction (MI) (type 5) has been controversial. This study aimed to evaluate the amount and pattern of cardiac biomarker release after elective OPCAB in patients without evidence of a new MI on cardiac magnetic resonance (CMR) imaging with late gadolinium enhancement (LGE).Patients with normal baseline cardiac biomarkers referred for elective OPCAB were prospectively included. CMR with LGE was performed in all patients before and after interventions. Measurements of troponin I (cTnI) and creatine kinase MB fraction (CK-MB) were systematically performed before and after the procedure. Patients with new LGE on the postprocedure CMR were excluded.All of the 53 patients without CMR evidence of a procedure-related MI after OPCAB exhibited a cTnI elevation peak above the 99th percentile. In 48 (91%), the peak value was >10 times this threshold. However, 41 (77%) had a CK-MB peak above the limit of the 99th percentile, and this peak was >10 times the 99th percentile in only 7 patients (13%). The median peak release of cTnI was 0.290 (0.8-3.7) ng/mL, which is 50-fold higher than the 99th percentile.In contrast with CK-MB, considerable cTnI release often occurs after an elective OPCAB procedure, despite the absence of new LGE on CMR.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Consolidated Standards of Reporting Trials diagram. CMR = cardiac magnetic resonance, LGE = late gadolinium enhancement, ONCAP = on-pump coronary artery bypass, OPCAB = off-pump coronary artery bypass, PCI = percutaneous coronary intervention.
Figure 2
Figure 2
Proportions of the release of cardiac biomarkers.
Figure 3
Figure 3
Distribution of cTn release for each time of evaluation. Continuous line shows the value of the 99th percentile. Dotted line shows the value of 10 times the 99th percentile.
Figure 4
Figure 4
Distribution of CK-MB release at each time of evaluation in male patients. Continuous line shows the value of the 99th percentile. Dotted line shows the value of 10 times the 99th percentile. CK-MB = creatine kinase MB fraction.
Figure 5
Figure 5
Distribution of CK-MB release at each time of evaluation in female patients. Continuous line shows the value of the 99th percentile. Dotted line shows the value of 10 times the 99th percentile. CK-MB = creatine kinase MB fraction.
See this image and copyright information in PMC

References

    1. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551–67. - PubMed
    1. Mohammed AA, Agnihotri AK, van Kimmenade RR, et al. Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery. Circulation 2009;120:843–50. - PubMed
    1. Hueb W, Gersh BJ, Rezende PC, et al. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial. BMC Cardiovasc Disord 2012;12:65. - PMC - PubMed
    1. Hueb W, Gersh BJ, Alves da Costa LM, et al. Accuracy of myocardial biomarkers in the diagnosis of myocardial infarction after revascularization as assessed by cardiac resonance: the Medicine, Angioplasty, Surgery Study V (MASS-V) Trial. Ann Thorac Surg 2016;101:2202–8. - PubMed
    1. Borst C, Jansen EW, Tulleken CA, et al. Coronary artery bypass grafting without cardiopulmonary bypass and without interruption of native coronary flow using a novel anastomosis site restraining device (“Octopus”). J Am Coll Cardiol 1996;27:1356–64. - PubMed